Announcement under Regulation 30 (LODR)-Change in Management
Bls Polymers Limited operates in Specialty Chemicals within the Materials sector.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM | ₹53,020 Cr | ₹55,219 Cr | ₹5,853 Cr | ₹1,484 Cr | 25.8% | ₹679 Cr | 11.5% | 11.1% | 7.6% | 401 |
| Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR | ₹49,551 Cr | ₹50,777 Cr | ₹4,066 Cr | ₹1,393 Cr | 32.6% | ₹911 Cr | 20% | 21.6% | 20.1% | 61 |
| Aether Industries LimitedAETHERAETHER | ₹21,708 Cr | ₹22,150 Cr | ₹1,296 Cr | ₹406 Cr | 31.3% | ₹249 Cr | 19.8% | 13.2% | 9.4% | 330 |
| Aarti Industries LimitedAARTIINDAARTIIND | ₹17,527 Cr | ₹22,448 Cr | ₹10,580 Cr | ₹1,457 Cr | 14.1% | ₹594 Cr | 5.1% | 8.8% | 7.3% | 54 |
| Fine Organic Industries LimitedFINEORGFINEORG | ₹16,377 Cr | ₹16,422 Cr | ₹2,604 Cr | ₹585 Cr | 20.4% | ₹482 Cr | 17.6% | 21.6% | 16.8% | 113 |
| Atul LimitedATULATUL | ₹15,423 Cr | ₹15,603 Cr | ₹6,969 Cr | ₹1,168 Cr | 16.4% | ₹772 Cr | 11% | 14.1% | 11.5% | 70 |
| Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM | ₹13,635 Cr | ₹13,783 Cr | ₹710 Cr | ₹251 Cr | 34.6% | ₹189 Cr | 27.1% | 31.1% | 25.2% | 366 |
| Anupam Rasayan India LimitedANURASANURAS | ₹13,564 Cr | ₹15,378 Cr | ₹2,609 Cr | ₹614 Cr | 22.2% | ₹180 Cr | 9.4% | 9.1% | 5.5% | 377 |
| Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL | ₹13,177 Cr | ₹14,187 Cr | ₹2,753 Cr | ₹684 Cr | 25.2% | ₹369 Cr | 12.4% | 27.7% | 25.2% | 158 |
| Basf India LimitedBASFBASF | ₹12,804 Cr | ₹12,804 Cr | ₹16,963 Cr | ₹878 Cr | 4.4% | ₹598 Cr | 2.8% | 14% | 11.1% | 40 |
| Vinati Organics LimitedVINATIORGAVINATIORGA | ₹11,470 Cr | ₹11,470 Cr | ₹2,511 Cr | ₹623 Cr | 29.4% | ₹412 Cr | 19.9% | 18.8% | 14.9% | 152 |
| Elantas Beck India LimitedELANTASELANTAS | ₹9,820 Cr | ₹9,820 Cr | ₹778 Cr | ₹147 Cr | 20.3% | ₹136 Cr | 17.4% | 20.6% | 15.8% | 70 |
Documents link to external sources (exchange filings, company investor pages).
Corporate actions, results dates and filings will appear here once ingested.
Standalone figures
| Ratio | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Margins | ||||
| Gross margin % | 26.1% | 29.2% | 42.4% | 51.4% |
| EBITDA margin % | 5.2% | 5.5% | 9.7% | 12% |
| EBIT margin % | 4.4% | 4.6% | 8.7% | 11.2% |
| PAT margin % | 2% | 2.5% | 6.4% | 7.7% |
| Working capital | ||||
| Receivable days | 72 | 77 | 82 | 76 |
| Inventory days | 101 | 109 | 105 | 156 |
| Payable days | — | — | — | — |
| NWC days | — | — | — | — |
| Leverage | ||||
| Current ratio | 22.68 | 19.4 | 7.45 | 6.57 |
| Debt to EBITDA | 5.49 | 5.71 | 2.33 | 1.23 |
| Debt to equity | 2.28 | 2 | 1.09 | 0.54 |
| Interest coverage | 2.2 | 2.1 | 4.3 | 5.5 |
| Asset turnover | 1.95 | 1.76 | 1.83 | 1.7 |
| Return ratios | ||||
| Return on assets % | 3.9% | 4.5% | 11.8% | 13.1% |
| Return on capital employed % | 10.3% | 11.9% | 23.2% | 26.1% |
| Return on equity % | 15.9% | 16.1% | 31.1% | 28.5% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
Promoter holding up 0 percentage points since Sep 2026.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 9 Nov 2026 | PLUTUS WEALTH MANAGEMENT LLP | Bulk | NSE | Sell | 3,66,269 | ₹238.25 | ₹8.73 Cr |
| 9 Nov 2026 | PLUTUS WEALTH MANAGEMENT LLP | Bulk | NSE | Buy | 3,66,269 | ₹238.15 | ₹8.72 Cr |
| 5 Nov 2026 | PLUTUS WEALTH MANAGEMENT LLP | Bulk | NSE | Buy | 18,60,597 | ₹256.54 | ₹47.73 Cr |
| 5 Nov 2026 | PLUTUS WEALTH MANAGEMENT LLP | Bulk | NSE | Sell | 18,60,597 | ₹256.59 | ₹47.74 Cr |
| 5 Nov 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | NSE | Buy | 7,58,568 | ₹256.86 | ₹19.48 Cr |
| 5 Nov 2026 | MICROCURVES TRADING PRIVATE LIMITED | Bulk | NSE | Sell | 7,58,568 | ₹256.99 | ₹19.49 Cr |
| 5 Nov 2026 | DIPAN MEHTA COMMODITIES PRIVATE LIMITED | Bulk | NSE | Buy | 7,51,816 | ₹255.99 | ₹19.25 Cr |
| 5 Nov 2026 | DIPAN MEHTA COMMODITIES PRIVATE LIMITED | Bulk | NSE | Sell | 7,47,021 | ₹256.64 | ₹19.17 Cr |
| 5 Nov 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | NSE | Sell | 6,78,962 | ₹257.40 | ₹17.48 Cr |
| 5 Nov 2026 | ALPHAGREP SECURITIES PRIVATE LIMITED | Bulk | NSE | Buy | 6,78,962 | ₹257.27 | ₹17.47 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
No scheme among the 32 fund houses on record reported a position in Bls Polymers Limited. Portfolios are published monthly by each AMC; coverage is still partial.
Announcement under Regulation 30 (LODR)-Change in Management
Appointment of Company Secretary and Compliance Officer
Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''''SEBI Listing Regulations'''')
Disclosure Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 - Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
Closure of Trading Window
Listing of Equity Shares of BLS Polymers Ltd
| Date | Category | Subject | Filing |
|---|---|---|---|
| 6 Nov 2026, 5:41 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management | |
| 6 Nov 2026, 5:33 pm | Company Update Appointment of Company Secretary / Compliance Officer | Appointment of Company Secretary and Compliance Officer |
| 3 Nov 2026, 8:44 pm | Company Update General | Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
| 3 Nov 2026, 4:32 pm | Company Update General | Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 |
| 3 Nov 2026, 4:23 pm | Company Update General | Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''''SEBI Listing Regulations'''') |
| 3 Nov 2026, 4:09 pm | Company Update General | Disclosure Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations, 2015 - Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information |
| 3 Nov 2026, 2:37 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
| 3 Nov 2026, 8:15 am | New Listing | Listing of Equity Shares of BLS Polymers Ltd | — |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 315 | 296 | 328 | 349 | |
| COGS | 232 | 210 | 189 | 170 |
| Gross profit | 82 | 86 | 139 | 179 |
| 66 | 70 | 107 | 138 | |
| Operating profit (EBITDA) | 16 | 16 | 32 | 42 |
| OPM % | 5.2% | 5.5% | 9.7% | 12% |
| Depreciation | 2 | 3 | 3 | 3 |
| Interest | 7 | 9 | 9 | 8 |
| 2 | 5 | 8 | 5 | |
| Profit before tax | 9 | 10 | 28 | 36 |
| Tax | 3 | 2 | 7 | 9 |
| Tax % | 28.7% | 22.4% | 25.2% | 25% |
| 6 | 8 | 21 | 27 | |
| PAT margin % | 2% | 2.5% | 6.4% | 7.7% |
| EPS (₹) | — | — | — | — |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity capital | 10 | 10 | 10 | 45 |
| Reserves | 30 | 37 | 58 | 50 |
| 90 | 94 | 74 | 52 | |
| 32 | 28 | 37 | 59 | |
| Total equity & liabilities | 161 | 168 | 179 | 206 |
| 18 | 18 | 18 | 20 | |
| CWIP | — | 0 | 0 | 2 |
| Investments | — | — | — | — |
| 143 | 150 | 162 | 184 | |
| Total assets | 161 | 168 | 179 | 206 |
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| -9 | 3 | 25 | 38 | |
| Cash from investing | -4 | -1 | 1 | -6 |
| Cash from financing | 12 | -2 | -26 | -31 |
| Net cash flow | -1 | -0 | -0 | 1 |
| Free cash flow | — | — | — | — |
| CFO / Operating profit % | -54.7% | 16.2% | 79.1% | 90.8% |